We do promote VOXIVA products by installing Franchisee & PCD Partners
with monopoly rights in specified areas. Promotional inputs like MR
Bag, Visual-Aids, Literatures, Reminders and Gifts/Stationary items are
provided free of cost.
Sales incentive schemes are introduced as per company’s policies for achieving the targets.
Doctor’s meetings are also arranged periodically to discuss the efficacy of existence product and introducing new molecules.
We are looking for District wise Pharma Franchise & Pharma PCD in following State:
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chhattisgarh
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu and Kashmir
- Jharkhand
- Karnataka
- Kerala
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha(Orissa)
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Tripura
- Uttar Pradesh
- Uttarakhand
- West Bengal
Union Territories
- Andaman and Nicobar Islands
- Chandigarh
- Dadra and Nagar Haveli
- Daman and Diu
- Lakshadweep
- National Capital Territory of Delhi
- Puducherry (Pondicherry)
If you are really interested to be associated
with us and engage your territory initially to enjoy monopoly, then you
can contact us.
3rd Party Manufacturing
We do facilitate 3rd party manufacturing for
different ranges either combining with our own combinations or
customized for other molecules as per demand.
Our list of 3rd party manufacturing has grown up astronomically in past 3 years.
Drug-Testing facility available locally is also extended to such parties desirous of using for their 3rd party manufactured products at reasonable rates.
Our list of 3rd party manufacturing has grown up astronomically in past 3 years.
Drug-Testing facility available locally is also extended to such parties desirous of using for their 3rd party manufactured products at reasonable rates.
Promotional Inputs
We are helping our associates and other parties to evolve and develop promotional inputs at very reasonable rates.
visit us at www.voxivapharma.com for more details.
-----------------------------------------------------------------------------------------------------------------
No comments:
Post a Comment